OC-0562: Exploiting tumor DNA repair status and hypoxia with CP-506, a novel hypoxia-activated prodrug
| Autor: | Van der Wiel, A., Marcus, D., Niemans, R., Yaromina, A., Theys, J., Mowday, A., Ashoorzadeh, A., Anderson, R., Bull, M., Abbattista, M., Heyerick, A., Guise, C., Smaill, J., Patterson, A., Dubois, L., Lambin, P. |
|---|---|
| Zdroj: | In Radiotherapy and Oncology November 2020 152 Supplement 1:S313-S314 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect